While several studies have suggested a role for the forces a cell experiences while in vascular flow, FSS, in creating more aggressive metastatic tumors, the underlying genotypic and phenotypic changes that are altered when ER+ breast cancer cells are exposed to FSS have not been fully elucidated. The gene discussed is ESR1; the disease is breast carcinoma.